American Thoracic Society (ATS)

ATS Statement on Latest COVID-19 Policy Actions: Convalescent Plasma and Testing of Asymptomatic Patients

Newswise — Aug. 28, 2020 -- The American Thoracic Society is alarmed by two federal agency policy actions that may significantly impact our nation’s COVID-19 response. This week, the FDA issued an emergency use authorization (EUA) for the use of convalescent plasma to treat COVID-19 disease.  This action was taken despite a lack of adequate evidence demonstrating a clear benefit for most patients. As pulmonary and critical care clinicians and researchers who treat individuals with COVID-19, we are concerned that an EUA for convalescent plasma has the potential to put patients at risk. 

While convalescent plasma currently indicates promise as a treatment for some patients with COVID-19, more study is needed to determine who might benefit from treatment, when treatment is most effective and what risks might accrue to patients treated with it. Answers to these important questions will only be gained through rigorous clinical trials, ideally randomized controlled trials.  However, this EUA may discourage enrollment in clinical trials, may lead to use in low-volume settings where outcomes are generally worse, and may limit monitoring of adverse treatment outcomes.

We are also deeply concerned that the lack of transparency surrounding the EUA announcement has undermined the scientific credibility of the FDA. The ATS urges the FDA to publicly disclose the evidence base for issuing the EUA in the context of concerns raised by the scientific community, including the NIH leadership, to reassure the community and ensure public confidence in the FDA decision making process.

Secondly, the ATS is gravely concerned by the CDC’s revised guidance on COVID-19 testing. Public health evidence clearly indicates that asymptomatic individuals are important source vectors of SARS-CoV2 community transmission. Testing asymptomatic individuals who are close contacts of those known to have COVID-19 infection is an evidence-based public health intervention that slows infectious disease transmission, along with other critical interventions including contact tracing and isolation.  It is unclear what the scientific rationale is for changes that will lead to reduced testing of asymptomatic close contacts of COVID-19 positive individuals.

In addition, the revised CDC guidance was communicated to the public with insufficient clarification and little supporting evidence, leaving important interpretation to the lay press and general public, resulting in confusion for health professionals and the public. Changes in guidance without a clear scientific basis undermine trust in the CDC, our nation’s frontline public health agency, and has the potential to further hinder our COVID-19 response.

 The ATS recommends that the CDC restore the previous guidance on COVID testing and further, articulate a comprehensive plan for testing, contact tracing and isolation that minimizes community spread of SARS-CoV2. Finally, the ATS urges the Administration to adopt a comprehensive communication strategy that reinforces public confidence that decision-making on our pandemic response is driven by science and evidence-based public health practice, not politics.

 Share Via Twitter:
@atscommunity is deeply concerned by recent actions by @US_FDA and @CDCgov. Read our statement: WWW.THORACIC.ORG/covid/atscovid19-082820.pdf




Filters close

Showing results

110 of 4179
Released: 2-Dec-2020 7:40 AM EST
No country ‘immune’ to COVID-19 economic shock, but Asian nations will bounce back faster
University of Cambridge

Study uses forty years of quarterly data to project a lengthy global recession from COVID-19 – knocking 3% off world GDP by end of next year. The manufacturing bases of China and East Asia are predicted to fare better than most Western economies.

Released: 1-Dec-2020 7:10 PM EST
American College of Surgeons calls on Congress to prevent CMS Medicare Physician Fee Schedule from taking effect
American College of Surgeons (ACS)

The Medicare Physician Fee Schedule released today by the Centers for Medicare & Medicaid Services (CMS) will harm patients and further destabilize a health care system already under severe strain from the COVID-19 pandemic.

Newswise: UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates
Released: 1-Dec-2020 5:05 PM EST
UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates
University of Nevada, Las Vegas (UNLV)

Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to “normal life.” Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectiveness rate have received international applause, excitement furthered with estimates that doses could be ready as early as December.

Newswise: Why Older Adults Should Shop from Home While the Pandemic is Surging
Released: 1-Dec-2020 4:50 PM EST
Why Older Adults Should Shop from Home While the Pandemic is Surging
Rutgers University-New Brunswick

Leslie M. Kantor, professor and chair of the Department of Urban-Global Public Health at the Rutgers School of Public Health, talks about the new data from Public Health England, the country’s national health service, and explains why even the most independent seniors should avoid grocery shopping at this stage of the pandemic and how to use technology and help from family and friends.

Released: 1-Dec-2020 4:05 PM EST
Primary Care in a Pandemic: Spotting Mental Health Needs and More
Michigan Medicine - University of Michigan

The number of people dealing with mental distress caused by enduring months of pandemic, economic disruption and political turmoil is rising fast. And America’s primary care clinics are the front line for many of those mental health concerns. A new online toolkit aims to help primary care clinics cope with this influx, and draw from the expertise of mental health specialists and researchers.

Released: 1-Dec-2020 3:50 PM EST
New Study Finds Possible Link Between Sight-Threatening Eye Infection and Coronavirus
American Academy of Ophthalmology (AAO)

Researchers are warning of a possible link between a rare and devastating eye infection and COVID-19.

Released: 1-Dec-2020 2:40 PM EST
The claim that COVID-19 vaccines will cause more severe disease through antibody-dependent enhancement is not yet supported
Newswise

ADE has not been shown to occur in individuals that received COVID-19 vaccines to date.

Newswise: Supercomputers Help Model Potential SARS-CoV2 Protease Inhibitors for COVID-19
Released: 1-Dec-2020 1:55 PM EST
Supercomputers Help Model Potential SARS-CoV2 Protease Inhibitors for COVID-19
University of California San Diego

A team of researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19.


Showing results

110 of 4179

close
1.55534